Level Four Advisory Services’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Level Four Advisory Services’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-35,500	Closed	-$7.47K	–	880
2023 Q2	$7.47K	Hold	35,500	–	–	﹤0.01%	795
2023 Q1	$5.68K	Hold	35,500	–	–	﹤0.01%	757
2022 Q4	$19.7K	Hold	35,500	–	–	﹤0.01%	662
2022 Q3	$42K	Buy	+35,500	New	+$38.3K	﹤0.01%	532

Other funds holding INFI

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Level Four Advisory Services's INFI Position: Q3 2023 in Review

Level Four Advisory Services sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 35,500 shares — an estimated $7.47K sold.

Level Four Advisory Services first reported a position in INFI in Q3 2022 and held it in 4 quarters. The position peaked at $42K in Q3 2022. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

Level Four Advisory Services reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Level Four Advisory Services sold 35,500 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $7.47K.
Level Four Advisory Services first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2022 and held it in 4 quarters.
Level Four Advisory Services's Infinity Pharmaceuticals, Inc. position peaked at $42K in Q3 2022.
3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on Level Four Advisory Services's 13F filing for Q3 2023, filed 13 Nov 2023.